BMY vs LSF · P/E 17, rev $24.46B vs rev $55.2M
Bristol-Myers Squibb Company (BMY) versus Laird Superfood Inc (LSF) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Laird Superfood Inc (LSF) is a packaged foods company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LSF revenue for 2026-06-30 was $55.2M. Net income was -$54.2K. LSF currently screens at market cap $67.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LSF currently screens at market cap $67.1M.
Not investment advice. Open the BMY and LSF stock pages for the full models.
Not investment advice.